TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
ACET

Adicet Bio Inc

Healthcare · Biotechnology

6.40$ -29.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ACET
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– +2.1% +7.2% +2.1% -98.5% -87.8% +1,699.3% -45.7% +156.8% -100.0% – –
– -1.5% +4.1% -100.0% +1,500.0% +56.3% – – – +21.7% +6.1% -1.3%
– +16.7% +18.1% +312.4% -98.5% -87.7% +1,699.3% -45.7% +156.8% -124.4% – –
– +84.3% +13.8% +183.4% -12.6% +61.0% +44.9% +42.5% +45.6% +48.8% -6.3% -0.2%
– +6.9% +12.2% +5.0% -89.0% +3.1% +161.8% -2.4% +18.3% +0.9% +6.6% -18.8%
– +10.3% -100.0% +1,887,600.0% +22.6% +39.9% +76.3% +24.6% +37.1% +55.9% -16.1% -9.3%
– +28.6% -100.0% – – – – – – – – –
– -1.0% +88.3% +77.0% – – – +31.3% -54.5% -68.8% -84.0% +800.0%
– +29.3% -100.0% – – – – – – – – –
– +28.2% +30.0% -6.3% -103.1% – -14,915.8% – – – – –
– +29.9% -100.0% – – – – – – – – –
– +25.8% -100.0% – – – – – – – – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?